Table 1.
Characteristics of the study population.
| Parameters | RA Patients n = 45 | Control Group n = 45 |
|---|---|---|
| sex | F-32 M-13 | F-37 M-8 |
| age | 58.27 ± 13.45 years | 54.73 ± 15.50 |
| smoking | 10 | 2 |
| disease duration | 14.55 ± 13.12 years | |
| remission | yes 4; no 41 | |
| CRP | 18.26 ± 22.02 | |
| ESR | 28.33 ± 23.20 | |
| RF | 220.38 ± 333.60 | |
| ACPA | 1169.36 ± 4291.60 | |
| treatment | Methotrexate 17/45 | |
| Sulfasalazine 4/45 | ||
| No DMARDs 22/45 | ||
| Glucocorticosteroids 22/45 |
CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; RF: rheumatoid factor; ACPA: anti-citrullinated peptide antibodies; GCS: glucocorticosteroids; F: female; M: male.